The angiopoietin receptor Tie2 is atheroprotective in arterial endothelium
- PMID: 37476204
- PMCID: PMC7614785
- DOI: 10.1038/s44161-023-00224-y
The angiopoietin receptor Tie2 is atheroprotective in arterial endothelium
Abstract
Leukocytes and resident cells in the arterial wall contribute to atherosclerosis, especially at sites of disturbed blood flow. Expression of endothelial Tie1 receptor tyrosine kinase is enhanced at these sites, and attenuation of its expression reduces atherosclerotic burden and decreases inflammation. However, Tie2 tyrosine kinase function in atherosclerosis is unknown. Here we provide genetic evidence from humans and from an atherosclerotic mouse model to show that TIE2 is associated with protection from coronary artery disease. We show that deletion of Tie2, or both Tie2 and Tie1, in the arterial endothelium promotes atherosclerosis by increasing Foxo1 nuclear localization, endothelial adhesion molecule expression and accumulation of immune cells. We also show that Tie2 is expressed in a subset of aortic fibroblasts, and its silencing in these cells increases expression of inflammation-related genes. Our findings indicate that unlike Tie1, the Tie2 receptor functions as the dominant endothelial angiopoietin receptor that protects from atherosclerosis.
Conflict of interest statement
Competing interests O.S. is named as a co-inventor on a patent on peptides disrupting chemokine heteromers (WO2017/077062A1) and two patents on peptides neutralizing extracellular histones (WO2019/122127 A1 and WO2021209465A1). These patents are outside the scope of the current manuscript. O.S. is a scientfic advisor to Novo Nordisk and ResoTher Pharma. The other authors declare no competing interests.
Figures

















Comment in
-
Endothelial tyrosine kinase Tie2 counteracts atherosclerosis development.Nat Cardiovasc Res. 2023 Mar;2(3):232-233. doi: 10.1038/s44161-023-00251-9. Nat Cardiovasc Res. 2023. PMID: 39196025 No abstract available.
References
-
- Borén J, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 2020;41:2313–2330. doi: 10.1093/eurheartj/ehz962. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous